US Patent 11596692 PD-L1/STING conjugates and methods of use
Patent 11596692 was granted and assigned to Incyte on March, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115966920
Date of Patent
March 7, 2023
0Patent Application Number
166911500
Date Filed
November 21, 2019
0Patent Primary Examiner
Edits on 8 Mar, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+200 characters)
US Patent 11596692 PD-L1/STING conjugates and methods of use
Article
The present application relates to conjugates of STING agonists and small molecule modulators of the PD-1/PD-L1 protein/protein interaction, as well as methods of treating cancer using the conjugates.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115966920
Date of Patent
March 7, 2023
0Patent Application Number
166911500
Date Filed
November 21, 2019
0Patent Primary Examiner
Find more entities like US Patent 11596692 PD-L1/STING conjugates and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.